Development of a cytomegalovirus (CMV) vaccine is a priority. We evaluated a two component
alphavirus replicon particle vaccine expressing CMV gB or a pp65/IE1 fusion protein, …

The remarkable success of SARS CoV-2 mRNA-based vaccines and the ensuing interest in
mRNA vaccines and therapeutics have highlighted the need for a scalable clinical-enabling …

HIV-1 genetic diversity among circulating strains presents a major challenge for HIV-1 vaccine
development, particularly for developing countries where less sequence information is …

Introduction The purpose of the present study was to determine whether cytotoxic chemotherapeutic
agents administered prior to immunotherapy with gene vaccines could augment the …

Background Malignant melanoma is the deadliest form of skin cancer and is refractory to
conventional chemotherapy and radiotherapy. Therefore alternative approaches to treat this …

Purpose: Prostate-specific membrane antigen (PSMA) is an attractive target for active
immunotherapy. Alphavirus vaccines have shown promise in eliciting immunity to tumor antigens. …

Replicon particles based on Venezuelan equine encephalitis virus (VEE) contain a self‐replicating
RNA encoding the VEE replicase proteins and expressing a gene of interest in place …

We used a propagation-defective, single-cycle, alphavirus replicon vector system to produce
virus-like replicon particles (VRP) expressing the hemagglutinin (HA) and neuraminidase (…

A single cycle of viral replication is the time required for a virus to enter the host cell, replicate
its genome, and produce infectious progeny virions. The primate lentiviruses, human …

Induction of potent immune responses to self-antigens remains a major challenge in tumor
immunology. We have shown that a vaccine based on alphavirus replicon particles (VRP) …